Literature DB >> 21287666

GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium.

Yuuki Shiomi1, Shin Nishiumi, Makoto Ooi, Naoya Hatano, Masakazu Shinohara, Tomoo Yoshie, Yasuyuki Kondo, Keisuke Furumatsu, Hideyuki Shiomi, Hiromu Kutsumi, Takeshi Azuma, Masaru Yoshida.   

Abstract

BACKGROUND: Metabolomics provides data about all the metabolic processes of a cell or organism. So far, the changes that occur in the levels of metabolites during the development of colitis have not been fully elucidated. Here we examined the changes of metabolite levels in the serum and colon tissue of colitis mice using gas chromatography mass spectrometry (GC/MS) with the aim of achieving a detailed understanding of the pathogenesis of inflammatory bowel disease (IBD).
METHODS: To induce colitis, C57BL/6J mice were administered 3.0% dextran sulfate sodium (DSS) in their drinking water for 5 days and were subsequently given drinking water alone.
RESULTS: A total of 77 and 92 metabolites were detected in serum and colon tissue, respectively, and among the metabolites the compositions of TCA cycle intermediates and amino acids changed depending on the degree of colitis. Then, partial least square discriminant analysis (PLS-DA), a multiple classification analysis, showed distinct clustering and clear separation of the groups according to the degree of colitis. Furthermore, PLS-DA loadings plots revealed that succinic acid, indole-3-acetic acid, glutamic acid, and glutamine were the main contributors to the separation of each stage of colitis. In addition, it was revealed that supplementation with glutamine, the level of which was significantly decreased in the acute phase of colonic inflammation, attenuated colitis induced by DSS.
CONCLUSIONS: Our results suggest that metabolomics is capable of representing the various degrees of colitis, and our findings will aid in the discovery of therapeutic agents for IBD and other inflammatory disorders by metabolomic approaches.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287666     DOI: 10.1002/ibd.21616

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  44 in total

Review 1.  Diagnosis of gastroenterological diseases by metabolome analysis using gas chromatography-mass spectrometry.

Authors:  Masaru Yoshida; Naoya Hatano; Shin Nishiumi; Yasuhiro Irino; Yoshihiro Izumi; Tadaomi Takenawa; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2011-11-02       Impact factor: 7.527

2.  Regulation of the metabolite profile by an APC gene mutation in colorectal cancer.

Authors:  Tomoo Yoshie; Shin Nishiumi; Yoshihiro Izumi; Aya Sakai; Jun Inoue; Takeshi Azuma; Masaru Yoshida
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

3.  Biochemistry: succinate strikes.

Authors:  Luke A J O'Neill
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

Review 4.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

5.  Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice.

Authors:  Toshihiko Okada; Shinji Fukuda; Koji Hase; Shin Nishiumi; Yoshihiro Izumi; Masaru Yoshida; Teruki Hagiwara; Rei Kawashima; Motomi Yamazaki; Tomoyuki Oshio; Takeshi Otsubo; Kyoko Inagaki-Ohara; Kazuki Kakimoto; Kazuhide Higuchi; Yuki I Kawamura; Hiroshi Ohno; Taeko Dohi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.

Authors:  Tomasz Dawiskiba; Stanisław Deja; Agata Mulak; Adam Ząbek; Ewa Jawień; Dorota Pawełka; Mirosław Banasik; Agnieszka Mastalerz-Migas; Waldemar Balcerzak; Krzysztof Kaliszewski; Jan Skóra; Piotr Barć; Krzysztof Korta; Kornel Pormańczuk; Przemyslaw Szyber; Adam Litarski; Piotr Młynarz
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

7.  Metabolomics for the early detection of cisplatin-induced nephrotoxicity.

Authors:  Takeshi Ezaki; Shin Nishiumi; Takeshi Azuma; Masaru Yoshida
Journal:  Toxicol Res (Camb)       Date:  2017-08-29       Impact factor: 3.524

8.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

Review 9.  Metabolomics as a diagnostic tool in gastroenterology.

Authors:  Vicky De Preter; Kristin Verbeke
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 10.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.